Faeth Therapeutics, Inc. (FTH) Institutional Ownership Changes & 13F Activity
Faeth Therapeutics, Inc. (FTH). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Suvretta Capital Management, Llc, Avoro Capital Advisors Llc, Baker Bros. Advisors Lp, Balyasny Asset Management L.P., and Cormorant Asset Management, Lp.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Citadel Advisors Llc | Buy | +12,296 | — | 12,296 | $307.40K | Q2 2026 | Sep 02, 2026 |
| Suvretta Capital Management, Llc | Buy | +1,985,554 | +5747.1% | 2,020,103 | $50.50M | Q2 2026 | Aug 14, 2026 |
| Avoro Capital Advisors Llc | Buy | +1,444,039 | — | 1,444,039 | $36.10M | Q2 2026 | Aug 14, 2026 |
| Baker Bros. Advisors Lp | Buy | +1,286,411 | — | 1,286,411 | $32.16M | Q2 2026 | Aug 14, 2026 |
| Balyasny Asset Management L.P. | Buy | +1,025,993 | +6331.3% | 1,042,198 | $26.05M | Q2 2026 | Aug 14, 2026 |
| Cormorant Asset Management, Lp | Buy | +722,020 | +235.8% | 1,028,242 | $7.66M | Q2 2026 | Aug 14, 2026 |
| Fairmount Funds Management Llc | Buy | +722,020 | — | 722,020 | $18.05M | Q2 2026 | Aug 14, 2026 |
| Ra Capital Management, L.P. | Buy | +722,020 | — | 722,020 | $18.05M | Q2 2026 | Aug 14, 2026 |
| Logos Global Management Lp | Buy | +692,020 | +2306.7% | 722,020 | $18.05M | Q2 2026 | Aug 14, 2026 |
| B Group, Inc. | Buy | +610,169 | — | 610,169 | $15.25M | Q2 2026 | Aug 14, 2026 |
| Caligan Partners Lp | Buy | +503,465 | +399.6% | 629,467 | $15.74M | Q2 2026 | Aug 14, 2026 |
| Trails Edge Capital Partners, Lp | Buy | +390,335 | +312.3% | 515,335 | $12.88M | Q2 2026 | Aug 14, 2026 |
| Adar1 Capital Management, Llc | Buy | +361,010 | — | 361,010 | $9.03M | Q2 2026 | Aug 14, 2026 |
| Octagon Capital Advisors Lp | Buy | +361,010 | — | 361,010 | $9.03M | Q2 2026 | Aug 14, 2026 |
| Boxer Capital Management, Llc | Buy | +180,505 | — | 180,505 | $4.51M | Q2 2026 | Aug 14, 2026 |
| Alyeska Investment Group, L.P. | Buy | +144,404 | — | 144,404 | $3.61M | Q2 2026 | Aug 14, 2026 |
| Awm Investment Company, Inc. | Buy | +111,343 | — | 111,343 | $2.78M | Q2 2026 | Aug 14, 2026 |
| Boothbay Fund Management, Llc | Buy | +107,519 | +411.6% | 133,643 | $3.34M | Q2 2026 | Aug 14, 2026 |
| Ikarian Capital, Llc | Buy | +29,035 | +457.2% | 35,386 | $884.65K | Q2 2026 | Aug 14, 2026 |
| Superstring Capital Management Lp | Buy | +14,175 | — | 14,175 | $354.38K | Q2 2026 | Aug 14, 2026 |
| Barclays Plc | Buy | +12,412 | — | 12,412 | $310.30K | Q2 2026 | Aug 14, 2026 |
| Jane Street Group, Llc | Buy | +11,245 | +126.7% | 20,117 | $502.91K | Q2 2026 | Aug 14, 2026 |
| Xtx Topco Ltd | Buy | +9,608 | — | 9,608 | $240.20K | Q2 2026 | Aug 14, 2026 |
| Royal Bank Of Canada | Buy | +509 | — | 509 | $13.00K | Q2 2026 | Aug 14, 2026 |
| Quarry Lp | Buy | +32 | — | 32 | $800.00 | Q2 2026 | Aug 14, 2026 |
| Affinity Asset Advisors, Llc | Buy | +144,404 | — | 144,404 | $3.61M | Q2 2026 | Aug 13, 2026 |
| Marshall Wace, Llp | Buy | +140,778 | +214.2% | 206,508 | $5.16M | Q2 2026 | Aug 13, 2026 |
| Ubs Group Ag | Buy | +17,012 | +375.6% | 21,541 | $538.52K | Q2 2026 | Aug 13, 2026 |
| Renaissance Technologies LLC | Sell | -11,625 | -36.3% | 20,416 | $510.40K | Q2 2026 | Aug 13, 2026 |
| Morgan Stanley | Buy | +8,534 | +97.0% | 17,329 | $433.23K | Q2 2026 | Aug 13, 2026 |
Frequently asked questions about FTH activity
Which institutional owners are buying FTH?
Institutional owners buying FTH include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in FTH activity?
"Buy" means an investor increased their reported position in FTH compared to the prior reporting period. This reflects growing exposure to Faeth Therapeutics, Inc. (FTH) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in FTH increasing?
Institutional interest in FTH can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.